Evolution of hepatosplenic plasmacytoma in a patient with multiple myeloma receiving chemotherapy

Am J Hematol. 2005 Jan;78(1):82-3. doi: 10.1002/ajh.20242.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Disease Progression
  • Female
  • Humans
  • Liver Neoplasms / chemically induced*
  • Liver Neoplasms / diagnostic imaging
  • Melphalan / administration & dosage
  • Multiple Myeloma / drug therapy*
  • Plasmacytoma / chemically induced*
  • Plasmacytoma / diagnostic imaging
  • Prednisolone / administration & dosage
  • Splenic Neoplasms / chemically induced*
  • Splenic Neoplasms / diagnostic imaging
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents, Alkylating
  • Antineoplastic Agents, Hormonal
  • Prednisolone
  • Melphalan